 efficaci safeti intraven nicardipin control postop hypertens IV nicardipin studi group double-blind studi efficaci safeti intraven IV nicardipin placebo control postop hypertens cardiac noncardiac surgic patient twenty-two patient cardiac noncardiac surgeri entri criteria systol BP equal mm Hg diastol BP equal mm Hg IV nicardipin placebo therapeut respons equal percent reduct BP baselin percent patient IV vs percent placebo mean respons time infus rate IV nicardipin minut mg/h magnitud BP reduct similar cardiac noncardiac postsurg patient blood pressur control minim dose adjust IV nicardipin mg/h prolong mainten infus period reflex mean increas heart rate bpm patient IV nicardipin sixteen patient noncardiac cardiac surgeri sustain heart rate bpm mean increas bpm baselin patient tachycardia nicardipin none patient develop tachycardia nicardipin therapi ST segment chang ischemia patient tachycardia baselin ST segment depress mm nicardipin treatment follow discontinu nicardipin therapi applic nitroglycerin nitropast hemodynam evalu IV mean arteri pressur system vascular resist cardiac index chang heart rate hemodynam chang similar cardiac noncardiac surgic patient advers experi IV nicardipin hypotens percent percent percent placebo group incid advers experi percent equal distribut hypotens percent percent headach percent import chang laboratori variabl IV nicardipin conclus find nicardipin titrat intraven calcium channel blocker postop hypertens cardiac noncardiac surgic patient